Adherence and biofilm formation of non-Candida albicans Candida species

Trends in Microbiology

Volumn 19, Issue 5, 2011, Pages 241-247

  Silva, Sónia ^a   Negri, Melyssa ^a   Henriques, Mariana ^a   Oliveira, Rosário ^a   Williams, David W ^b   Azeredo, Joana ^a  

^a UNIVERSITY OF MINHO   (Portugal)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC PROTEINASE;

BIOFILM; BLOODSTREAM INFECTION; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDEMIA; CANDIDIASIS; CELL ADHESION; CELL SURFACE; CELL WALL; DISEASE COURSE; ENZYME RELEASE; FUNGAL CELL; FUNGAL COLONIZATION; FUNGAL GENETICS; FUNGAL PHENOMENA AND FUNCTIONS; FUNGAL STRAIN; FUNGAL VIRULENCE; FUNGUS ADHERENCE; FUNGUS GROWTH; HEMOLYSIS; HOSPITAL INFECTION; HOST PATHOGEN INTERACTION; HUMAN; HYDROLYSIS; HYDROPHOBICITY; MICROBIAL ACTIVITY; MORBIDITY; MORTALITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN TARGETING; REVIEW;

BIOFILMS; CANDIDA; CANDIDIASIS; CELL ADHESION; HUMANS;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS;

EID: 79955467634     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tim.2011.02.003     Document Type: Review

References (75)

1. Fidel P.L., et al. Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin. Microbiol. Rev. 1999, 12:80-96.
2. Trofa D., et al. Candida parapsilosis, an emerging fungal pathogen. Clin. Microbiol. Rev. 2008, 21:606-662.
3. Pfaller M.A., Diekema D.J. Epidemiology of invasive candidiasis: a persistent public health problem. Clin. Microbiol. Rev. 2007, 20:133-163.
4. Kothavade R.J., et al. Candida tropicalis: its prevalence, pathogenicity and increasing resistance to fluconazole. J. Med. Microbiol. 2010, 59:873-880.
5. Liguori G., et al. Oral candidiasis: a comparison between conventional methods and multiplex polymerase chain reaction for species identification. Oral Microbiol. Immunol. 2009, 24:76-78.
6. Kotloff R.M., et al. Pulmonary complications of solid organ and hematopoietic stem cell transplantation. Am. J. Resp. Crit. Car. Med. 2004, 170:22-48.
7. Kojic E.M., Darouichee R.O. Candida infections of medical devices. Clin. Microbiol. Rev. 2004, 17:255-267.
8. Gonzalez G.H., et al. Oral Candidiasis in children and adolescents with cancer. Identification of Candida spp. Med. Oral Patol. Oral Cir. Bucal. 2007, 12:419-423.
9. Calderone R.A. Introduction and historical perspectives. Candida and candidiasis 2002, 15-25. ASM Press, Washington D.C. R. Calderone (Ed.).
10. Chandra J., et al. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J. Bacteriol. 2001, 183:5385-5394.
11. Henriques M., et al. Experimental methodology to quantify Candida albicans cell surface hydrophobicity. Biotechnol. Lett. 2002, 24:1111-1115.
12. Chaffin W.L. Candida albicans cell wall proteins. Microbiol. Mol. Biol. Rev. 2008, 72:495-544.
13. Hazen K.C., et al. Influence of growth conditions on cell surface hydrophobicity of Candida albicans and Candida glabrata. Infect. Immun. 1986, 54:269-271.
14. Kikutani H., Makino S. The murine autoimmune diabetes model: NOD and related strains. Adv. Immunol. 1992, 51:285-322.
15. Camacho D., et al. The effect of chlorhexidine and gentian violet on the adherence of Candida spp. to urinary catheters. Mycopathologia 2007, 163:261-266.
16. Panagoda G.J., et al. Adhesion of Candida parapsilosis to epithelial and acrylic surfaces correlates with cell surface hydrophobicity. Mycoses 2001, 44:29-35.
17. Silva S., et al. Silicone colonisation by non-Candida albicans Candida species in the presence of urine. J. Med. Microbiol. 2010, 59:747-754.
18. Luo G., Samaranayake L.P. Candida glabrata, an emerging fungal pathogen, exhibits superior relative cell surface hydrophobicity and adhesion to denture acrylic surfaces compared with Candida albicans. APMIS 2002, 110:601-610.
19. Negri M., et al. Crystal violet expedite method for quantification adhesion to epithelial cells. Br. J. Microbiol. 2010, 67:120-125.
20. Negri M., et al. Examination of potential virulence factors of Candida tropicalis clinical isolates from hospitalized patients. Mycopathologia 2010, 169:175-182.
21. Groot P.W.J., et al. The cell wall of the human pathogen Candida glabrata: differential incorporation of novel adhesin-like wall proteins. Eukaryotic Cell 2008, 7:1951-1964.
22. De Las Penas A., et al. Virulence-related surface glycoproteins in the yeast pathogen Candida glabrata are encoded in subtelomeric clusters and subject to RAP1- and SIR-dependent transcriptional silencing. Genes Dev. 2003, 17:2245-2258.
23. Zupancic M.L., et al. Glycan microarray analysis of Candida glabrata adhesin ligand specificity. Mol. Microb. 2008, 68:547-559.
24. Ma B., et al. Assimilation of NAD+ precursors in Candida glabrata. Mol. Microb. 2007, 66:14-25.
25. Cormack B.P., et al. An adhesin of the yeast pathogen Candida glabrata mediating adherence to human epithelial cells. Science 1999, 285:578-582.
26. Domergue R., et al. Nicotinic acid limitation regulates silencing of Candida adhesins during UTI. Science 2005, 308:866-870.
27. Butler G., et al. Evolution of pathogenicity and sexual reproduction in eight Candida genomes. Nature 2009, 459:657-662.
28. Hoyer L.L., et al. Characterization of agglutinin-like sequence genes from non-albicans Candida and phylogenetic analysis of the ALS family. Genetics 2001, 157:1555-1567.
29. Schaller M., et al. Models of oral and vaginal candidiasis based on in vitro reconstituted human epithelia. Nat. Protoc. 2006, 1:2767-2773.
30. Silva S., et al. Characterization of Candida parapsilosis infection of an in vitro reconstituted human oral epithelium. Eur. J. Oral Sci. 2009, 117:669-675.
31. Gácser A., et al. Virulence of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis in reconstituted human tissue models. Fungal Genet. Biol. 2007, 44:1336-1341.
32. Jayatilake, et al. Quantitative evaluation of tissue invasion by wild type, hyphal and SAP mutants of Candida albicans, and non-albicans Candida species in reconstituted human oral epithelium. J. Oral Pathol. Med. 2006, 35:481-491.
33. Monod M., et al. Secreted proteases from pathogenic fungi. Int. J. Med. Microbiol. 2002, 292:405-419.
34. Ruchel R., et al. Candida acid proteases. J. Med. Vet. Mycol. 2004, 30(Suppl. 1):123-132.
35. Pichova I., et al. Secreted aspartic proteases of Candida albicans, Candida tropicalis, Candida parapsilosis and Candida lusitaniae. Inhibition with peptidomimetic inhibitors. Eur. J. Biochem. 2001, 268:2669-2677.
36. Chakrabarti A., et al. In vitro proteinase production by Candida species. Mycopathologia 1991, 114:163-168.
37. Kobayashi C., et al. Candiduria in hospital patients: a study prospective. Mycopathologia 2004, 158:49-52.
38. Merkerova M., et al. Cloning and characterization of Sapp2p, the second aspartic proteinase isoenzyme from Candida parapsilosis. FEMS Yeast Res. 2006, 6:1018-1026.
39. Dagdeviren M., et al. Acid proteinase, phospholipase and adherence properties of Candida parapsilosis strains isolated from clinical specimens of hospitalised patients. Mycoses 2005, 48:321-326.
40. Zaugg C., et al. Secreted aspartic proteinase family of Candida tropicalis. Infect. Immun. 2001, 69:405-412.
41. Togni G., et al. Isolation and nucleotide sequence of the extracellular acid protease gene (ACP) from the yeast Candida tropicalis. FEBS Lett. 1991, 286:181-185.
42. Symersky J., et al. High-resolution structure of the extracellular apartic proteinase from Candida tropicalis yeast. Biochemistry 1997, 36:12700-12710.
43. Borg M., Ruchel R. Demonstrating of fungal proteinase during pahocytosis of Candida albicans and Candida tropicalis. J. Med. Vet. Mycol. 1990, 28:3-14.
44. Silva S., et al. The role of secreted aspartyl proteinases in Candida tropicalis invasion and damage of oral mucosa. Clin. Microbiol. Infect. 2011, 17:264-272.
45. Lermann U., Morschhauser J. Secreted aspartic proteases are not required for invasion of reconstituted human epithelia by Candida albicans. Microbiology 2008, 154:3281-3295.
46. Naglik J.R., et al. Quantitative expression of the Candida albicans secreted aspartyl proteinase gene family in human oral and vaginal candidiasis. Microbiology 2008, 154:3266-3280.
47. Correia A., et al. Limited role of secreted aspartyl proteinases Sap1 to Sap6 in Candida albicans virulence and host immune response in murine hematogenously disseminated candidiasis. Infect. Immun. 2010, 78:4839-4849.
48. Mukherjee P.K., et al. Reintroduction of the PLB1 gene into Candida albicans restores virulence in vivo. Microbiology 2001, 147:2585-2597.
49. Ghannoum M.A. Potential role of phospholipases in virulence and fungal pathogenesis. Clin. Microbiol. Rev. 2000, 13:122-143.
50. Galan-Ladero M.A., et al. Enzymatic activities of Candida tropicalis isolated from hospitalized patients. Med. Mycol. 2010, 48:207-210.
51. Cafarchia C., et al. Phospholipase activity of yeasts from wild birds and possible implications for human disease. Med. Mycol. 2008, 46:429-434.
52. Furlaneto-Maia L., et al. In vitro evaluation of putative virulence attributes of oral isolates of Candida spp. obtained from elderly healthy individuals. Mycopathologia 2007, 166:209-217.
53. Dostal J., et al. The precusor of secreted aspartic proteinase Sapp1p from Candida parapsilosis can be activated both autocatalytically and by membrane bound processing proteinase. Biol. Chem. 2005, 386:791-799.
54. Hube B., et al. The role and relevance of phospholipase D1 during growth and dimorphism of Candida albicans. Microbiology 2001, 147:879-889.
55. Gácser A., et al. Lipase 8 affects the pathogenesis of Candida albicans. Infect. Immun. 2007, 75:4710-4718.
56. Brunel L., et al. High-level expression of Candida parapsilosis lipase/acyltransferase in Pichia pastoris. J. Biotechnol. 2004, 111:41-50.
57. Neugnot V., et al. The lipase/acyltransferase from Candida parapsilosis: molecular cloning and characterization of purified recombinant enzymes. Eur. J. Biochem. 2002, 269:1734-1745.
58. Filler S.G., et al. Candida albicans stimulates endothelial cell eicosanoid production. J. Infect. Dis. 1991, 164:928-935.
59. Luo G., et al. Candida species exhibit differential in vitro hemolytic activities. J. Clin. Microbiol. 2001, 39:2971-2974.
60. Watanabe T., et al. Characterization of a haemolytic factor from Candida albicans. Microbiology 1999, 145:689-694.
61. Manns J.M., et al. Production of a hemolytic factor by Candida albicans. Infect. Immun. 1994, 62:5154-5156.
62. Luo G., et al. Reverse transcriptase polymerase chain reaction (RT-PCR) detection of HLP gene expression in Candida glabrata and its possible role in in vitro haemolysin production. APMIS 2004, 112:283-290.
63. Ramage G., et al. Candida biofilms on implanted biomaterials: a clinically significant problem. FEMS Yeast Res. 2006, 6:979-986.
64. Silva S., et al. Biofilms of non-Candida albicans Candida species: quantification, structure and matrix composition. Med. Mycol. 2009, 47:681-689.
65. Mukherjee P.K., Chandra J. Candida biofilm resistance. Drug Resist. Updat. 2004, 7:301-309.
66. Kumamoto C.A. Candida biofilms. Curr. Opin. Microbiol. 2002, 5:608-611.
67. Jain N., et al. Biofilm formation by and antifungal susceptibility of Candida isolates from urine. Appl. Environ. Microbiol. 2007, 73:1697-1703.
68. Donlan R.M., Costerton J.W. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 2002, 15:167-193.
69. Kuhn D.M., et al. Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect. Immun. 2002, 70:878-888.
70. Iraqui I., et al. The Yak1p kinase controls expression of adhesins and biofilm formation in Candida glabrata in a Sir4p-dependent pathway. Mol. Microbiol. 2005, 55:1259-1271.
71. Lattif A.A., et al. Characterization of biofilms formed by Candida parapsilosis, C. metapsilosis, and C. orthopsilosis. Int. J. Med. Microbiol. 2010, 300:265-270.
72. Shin J.H., et al. Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources. J. Clin. Microbiol. 2002, 40:1244-1248.
73. Baillie G.S., Douglas L.J. Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. J. Antimicrob. Chemother. 2000, 46:397-403.
74. Al-Fattani M.A., Douglas L.J. Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance. J. Med. Microbiol. 2006, 55:999-1008.
75. Gacser A., et al. Targeted gene deletion in Candida parapsilosis demonstrates the role of secreted lipase in virulence. J. Clin. Invest. 2007, 117:3049-3058.